Valerian
Unnamed: 1
Unnamed: 2
Valeriana officinalis L. (Valerianaceae)





Synonym(s) and related species


All-heal


Belgian valerian


Common valerian


Fragrant valerian


Garden valerian





Monograph
Interpretation
Citation
Alcohol
The interaction between valerian and alcohol is based on experimental evidence only.
von Eickstedt K-W. Die Beeinflussung der Alkohol-Wirkung durch valepotriate. Arzneimittelforschung (1969) 19, 995–7.


Niteherb Tablets (Dry extract of valerian root). MH Pharma (UK) Ltd. UK Summary of product characteristics, December 2007.


Valdrian Capsules (Valerian root). Bio-Health Ltd. UK Summary of product characteristics, July 2008.
Barbiturates
The interaction between valerian and barbiturates is based on experimental evidence only.
Hendriks H, Bos R, Woerdenbag HJ, Koster AS. Central nervous depressant activity of valerenic acid in the mouse. Planta Med (1985) 51, 28–31.
Benzodiazepines
Valerian does not affect the pharmacokinetics of alprazolam or midazolam to a clinically relevant extent. However, additive sedative effects are a possibility.
Donovan JL, DeVane CL, Chavin KD, Wang J-S, Gibson BB, Gefroh HA, Markowitz JS. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metab Dispos (2004) 32, 1333–6.


Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther (2005) 77, 415–26.
Caffeine
Valerian does not affect the pharmacokinetics of caffeine to a clinically relevant extent. However, the stimulant effects of caffeine may oppose the hypnotic effects of valerian.
Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther (2005) 77, 415–26.
Chlorzoxazone
Valerian does not affect the pharmacokinetics of chlorzoxazone to a clinically relevant extent. However, additive sedative effects are a possibility.
Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther (2005) 77, 415–26.
Dextromethorphan
Valerian does not affect the pharmacokinetics of dextromethorphan to a clinically relevant extent.
Donovan JL, DeVane CL, Chavin KD, Wang J-S, Gibson BB, Gefroh HA, Markowitz JS. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metab Dispos (2004) 32, 1333–6.
Food
No interactions found.

Herbal medicines
For a report of a possible interaction between valerian and ginkgo, see Ginkgo + Herbal medicines; Valerian, page 214. For a case describing delirium in a patient taking St John’s wort, valerian and loperamide, see St John’s wort + Loperamide, page 373.

